政大機構典藏-National Chengchi University Institutional Repository(NCCUR):Item 140.119/114964

政大機構典藏 > 商學院 > 國際經營管理英語碩士學程IMBA > 學位論文 > Item 140.119/114964

Please use this identifier to cite or link to this item: https://nccur.lib.nccu.edu.tw/handle/140.119/114964

Title:	Genedex co. 營運計畫書 Genedex co. business plan
Authors:	王熙婷 Wang, Kate
Contributors:	蔡政憲 Tsai, Jason 王熙婷 Wang, Kate
Keywords:	OTC藥品分割人口高齡化學名藥 OTC drugs segment Aging population Generic drugs
Date:	2017
Issue Date:	2017-12-01 12:07:34 (UTC+8)
Abstract:	Aging population is becoming the potential social and economic problem for many governments all around the world. These countries including Taiwan are seeking for solutions for the increased healthcare spending. According to the United Nations’ population estimates, we are living in a rapidly aging world. The global share of what we call “senior” or people age over 65 is expected to rise from nearly 8% in 2015 to more than 14% by 2050. The situation in Taiwan is not much different. With increasing life expectancy and a birth rate that continues to decline, the aging population in Taiwan has become more and more obvious. Widespread adoption of Generic and Biosimilar drugs, as opposed to patented or brand name drugs, could help governments reduce healthcare costs and increase the reach of healthcare services. Patented drugs in the prescription drugs segment account for about 70% of total prescription spending in Taiwan. However, the share is set to decline gradually under pressure from government policies promoting the use of generic products and the increasing switches from prescription segment to OTC segment (RX-to-OTC). We expect the penetration of generic drugs in Taiwan OTC drugs segment to increase as the generic drug market has continued to gain prominence within the pharmaceutical sectors in recent years. Despite the fact that OTC generic drug market is a highly competitive market in Taiwan, Genedex Co. still aims to provide good quality generic drugs at a competitive price to meet the generic drugs demands. In addition, Genedex Co. understands the ability to quickly bring new products to the market will play a large role in the future success. Thus, product innovation and differentiation will also be the center focus in the business model. Looking into the future, Genedex Co. expects to see growth at a more rapid pace starting from year 2020 as newly developed generic OTC drugs will be introduced to the market to compete with the branded counterparts and also expects to achieve a more solid presence in the market by year 2021.
Reference:	IMS Health. http://www.imshealth.com/. Accessed August 2017. Industry & Technology Intelligence Service. http://www.itis.org.tw/Default.aspx . Accessed August 2017. KHS. https://www.gmdu.net/corp-831310.html. Accessed August 2017. Market Data Forecast. Market Data Forecast 2016 report. http://www.marketdataforecast.com/. Accessed August 2017. Shiner Pharm Corp. http://www.shinerpharm.com/about-us/ Accessed August 2017. Taiwan Directorate general of Budget Accounting and Statistics (DGBAS). http://eng.dgbas.gov.tw/mp.asp?mp=2. Accessed August 2017. United Nations. 2015. UN Global Population Prospects Report, 2015 Revision. https://esa.un.org/unpd/wpp/Publications/. Accessed August 2017. 台灣製藥工業同業公會. http://www.tpma.org.tw/. Accessed August 2017.
Description:	碩士國立政治大學國際經營管理英語碩士學位學程(IMBA) 102933013
Source URI:	http://thesis.lib.nccu.edu.tw/record/#G0102933013
Data Type:	thesis
Appears in Collections:	[國際經營管理英語碩士學程IMBA] 學位論文

Files in This Item:

There are no files associated with this item.

社群 sharing

Loading...